Kobayashi Y - Search Results

1

Cemiplimab monotherapy in Japanese patients with recurrent or metastatic cervical cancer.

Hasegawa K, Takahashi S, Ushijima K, Okadome M, Yonemori K, Yokota H, Vergote I, Monk BJ, Tewari KS, Fujiwara K, Li J, Jamil S, Paccaly A, Takehara K, Usami T, Aoki Y, Suzuki N, Kobayashi Y, Yoshida Y, Watari H, Seebach F, Lowy I, Mathias M, Fury MG, Oaknin A. Hasegawa K, et al. Among authors: kobayashi y. Cancer Med. 2024 Sep;13(18):e70236. doi: 10.1002/cam4.70236. Cancer Med. 2024. PMID: 39325020 Free PMC article. Clinical Trial.

2

Characteristic expression of globotriaosyl ceramide in human ovarian carcinoma-derived cells with anticancer drug resistance.

Kiguchi K, Iwamori Y, Suzuki N, Kobayashi Y, Ishizuka B, Ishiwata I, Kita T, Kikuchi Y, Iwamori M. Kiguchi K, et al. Among authors: kobayashi y. Cancer Sci. 2006 Dec;97(12):1321-6. doi: 10.1111/j.1349-7006.2006.00326.x. Epub 2006 Sep 21. Cancer Sci. 2006. PMID: 16995873 Free PMC article.

3

Enzymatic activities of uridine and thymidine phosphorylase in normal and cancerous uterine cervical tissues.

Kobayashi Y, Wada Y, Ohara T, Okuda Y, Suzuki N, Hasegawa K, Kiguchi K, Ishizuka B. Kobayashi Y, et al. Hum Cell. 2007 Nov;20(4):107-10. doi: 10.1111/j.1749-0774.2007.00036.x. Hum Cell. 2007. PMID: 17949350

4

Concurrent chemoradiotherapy with nedaplatin after radical hysterectomy in patients with stage IB and II cervical cancer.

Kobayashi Y, Ohara T, Wada Y, Okuda Y, Kondo H, Okuma Y, Suzuki N, Gomi H, Kiguchi K, Ishizuka B. Kobayashi Y, et al. J Obstet Gynaecol Res. 2009 Jun;35(3):490-4. doi: 10.1111/j.1447-0756.2008.00955.x. J Obstet Gynaecol Res. 2009. PMID: 19527388

5

[Usefulness of clinical study of irinotecan and cisplatin for recurrent ovarian cancer].

Yahagi N, Kobayashi Y, Ohara T, Kondo H, Suzuki N, Kiguchi K, Ishizuka B. Yahagi N, et al. Among authors: kobayashi y. Gan To Kagaku Ryoho. 2009 Dec;36(13):2583-6. Gan To Kagaku Ryoho. 2009. PMID: 20009459 Japanese.

6

Ovarian carcinoma complicated by sigmoid colon fistula formation: a case report and review of the literature.

Yahagi N, Kobayashi Y, Ohara T, Suzuki N, Kiguchi K, Ishizuka B. Yahagi N, et al. Among authors: kobayashi y. J Obstet Gynaecol Res. 2011 Mar;37(3):250-3. doi: 10.1111/j.1447-0756.2010.01341.x. Epub 2011 Jan 5. J Obstet Gynaecol Res. 2011. PMID: 21208339 Review.

7

Psychological characteristics of Japanese gynecologic cancer patients after learning the diagnosis according to the hospital anxiety and depression scale.

Suzuki N, Ninomiya M, Maruta S, Hosonuma S, Nishigaya Y, Kobayashi Y, Kiguchi K, Ishizuka B. Suzuki N, et al. Among authors: kobayashi y. J Obstet Gynaecol Res. 2011 Jul;37(7):800-8. doi: 10.1111/j.1447-0756.2010.01437.x. Epub 2011 Mar 31. J Obstet Gynaecol Res. 2011. PMID: 21450027

8

Clinical study on the efficacy of fluvoxamine for psychological distress in gynecologic cancer patients.

Suzuki N, Ninomiya M, Maruta T, Hosonuma S, Yoshioka N, Ohara T, Nishigaya Y, Kobayashi Y, Kiguchi K, Ishizuka B. Suzuki N, et al. Among authors: kobayashi y. Int J Gynecol Cancer. 2011 Aug;21(6):1143-9. doi: 10.1097/IGC.0b013e3181ffbeb9. Int J Gynecol Cancer. 2011. PMID: 21792017 Clinical Trial.

9

Combination of irinotecan (CPT-11) and nedaplatin (NDP) for recurrent patients with uterine cervical cancer.

Ohara T, Kobayashi Y, Yoshida A, Yoshioka N, Yahagi N, Kondo H, Tozawa A, Kiguchi K, Suzuki N. Ohara T, et al. Among authors: kobayashi y. Int J Clin Oncol. 2013 Dec;18(6):1102-6. doi: 10.1007/s10147-012-0487-4. Epub 2012 Oct 25. Int J Clin Oncol. 2013. PMID: 23095879

10

Survival with Cemiplimab in Recurrent Cervical Cancer.

Tewari KS, Monk BJ, Vergote I, Miller A, de Melo AC, Kim HS, Kim YM, Lisyanskaya A, Samouëlian V, Lorusso D, Damian F, Chang CL, Gotovkin EA, Takahashi S, Ramone D, Pikiel J, Maćkowiak-Matejczyk B, Guerra Alía EM, Colombo N, Makarova Y, Rischin D, Lheureux S, Hasegawa K, Fujiwara K, Li J, Jamil S, Jankovic V, Chen CI, Seebach F, Weinreich DM, Yancopoulos GD, Lowy I, Mathias M, Fury MG, Oaknin A; Investigators for GOG Protocol 3016 and ENGOT Protocol En-Cx9. Tewari KS, et al. N Engl J Med. 2022 Feb 10;386(6):544-555. doi: 10.1056/NEJMoa2112187. N Engl J Med. 2022. PMID: 35139273 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,558 results

Search Page

Filters